Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$7.35 - $13.21 $9,856 - $17,714
-1,341 Reduced 98.17%
25 $0
Q1 2023

May 11, 2023

BUY
$7.79 - $16.29 $3,513 - $7,346
451 Added 49.29%
1,366 $14,000
Q4 2022

Feb 10, 2023

BUY
$11.0 - $21.45 $3,289 - $6,413
299 Added 48.54%
915 $10,000
Q3 2022

Nov 10, 2022

BUY
$20.09 - $35.8 $10,265 - $18,293
511 Added 486.67%
616 $13,000
Q2 2022

Aug 09, 2022

SELL
$27.42 - $43.63 $712 - $1,134
-26 Reduced 19.85%
105 $3,000
Q1 2022

May 06, 2022

SELL
$36.48 - $52.22 $1,021 - $1,462
-28 Reduced 17.61%
131 $5,000
Q4 2021

Feb 01, 2022

SELL
$33.11 - $55.01 $2,085 - $3,465
-63 Reduced 28.38%
159 $7,000
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $1,051 - $1,387
21 Added 10.45%
222 $11,000
Q2 2021

Aug 09, 2021

SELL
$56.61 - $80.46 $5,547 - $7,885
-98 Reduced 32.78%
201 $13,000
Q1 2021

May 12, 2021

BUY
$86.23 - $125.19 $862 - $1,251
10 Added 3.46%
299 $28,000
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $4,987 - $7,022
63 Added 27.88%
289 $26,000
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $162,918 - $268,395
-1,989 Reduced 89.8%
226 $23,000
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $75,410 - $124,253
1,388 Added 167.84%
2,215 $175,000
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $1,874 - $2,612
38 Added 4.82%
827 $48,000
Q3 2019

Oct 24, 2019

BUY
$40.6 - $57.2 $30,044 - $42,328
740 Added 1510.2%
789 $39,000
Q2 2019

Jul 24, 2019

BUY
$39.92 - $53.86 $1,956 - $2,639
49 New
49 $2,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.